Literature DB >> 7958889

Tissue-specific gene activation by MyoD: determination of specificity by cis-acting repression elements.

H Weintraub1, T Genetta, T Kadesch.   

Abstract

MyoD is a muscle-specific transcriptional activator; E12 is a B-cell activator. An IgH enhancer is activated almost 100-fold by E12 but not at all by Myo; an MCK enhancer is activated almost 1000-fold by MyoD and not at all by E12. MyoD and E12 are both basic helix-loop-helix proteins that bind to similar E-box sequences (CANNTG); the IgH enhancer contains the same E boxes as the MCK enhancer, yet each retains exclusive specificity for either E12 or MyoD, respectively. We show that the IgH enhancer contains a cis-acting negative element that is directed at MyoD, but not at E12. This repression requires the mu E5 E box within the IgH enhancer; however, the specificity for repression, as opposed to activation, is associated with 2 bp flanking each side of the mu E5 E box. The target for repression of MyoD in the IgH enhancer is the bHLH region of MyoD. Our results suggest that MyoD only activates myogenic genes because nonmuscle enhancers that contain E boxes also contain negative elements that prevent MyoD activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7958889     DOI: 10.1101/gad.8.18.2203

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  34 in total

1.  Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations.

Authors:  T Kophengnavong; J E Michnowicz; T K Blackwell
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Identification of cyclin D3 as a direct target of E2A using DamID.

Authors:  Siyuan Song; Jonathan Cooperman; Danielle L Letting; Gerd A Blobel; John Kim Choi
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 3.  Regulation of cellular chromatin state: insights from quiescence and differentiation.

Authors:  Surabhi Srivastava; Rakesh K Mishra; Jyotsna Dhawan
Journal:  Organogenesis       Date:  2010 Jan-Mar       Impact factor: 2.500

4.  MyoD directly up-regulates premyogenic mesoderm factors during induction of skeletal myogenesis in stem cells.

Authors:  Peter J Gianakopoulos; Virja Mehta; Anastassia Voronova; Yi Cao; Zizhen Yao; Josée Coutu; Xiaonan Wang; Michelle S Waddington; Stephen J Tapscott; Ilona S Skerjanc
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

5.  Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis.

Authors:  Vahab D Soleimani; Hang Yin; Arezu Jahani-Asl; Hong Ming; Christel E M Kockx; Wilfred F J van Ijcken; Frank Grosveld; Michael A Rudnicki
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

6.  Role of negative regulation in promoter specificity of the homologous transcriptional activators Ace2p and Swi5p.

Authors:  P R Dohrmann; W P Voth; D J Stillman
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

7.  Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation.

Authors:  S E Johnson; X Wang; S Hardy; E J Taparowsky; S F Konieczny
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

8.  Determinants of myogenic specificity within MyoD are required for noncanonical E box binding.

Authors:  Analeah B Heidt; Anabel Rojas; Ian S Harris; Brian L Black
Journal:  Mol Cell Biol       Date:  2007-06-11       Impact factor: 4.272

9.  Differences between MyoD DNA binding and activation site requirements revealed by functional random sequence selection.

Authors:  J Huang; T K Blackwell; L Kedes; H Weintraub
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

10.  The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist.

Authors:  Y Hamamori; H Y Wu; V Sartorelli; L Kedes
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.